Procurement policy developed from

Our focus is on a particular innovative procurement mechanism value-based pricing of medicines. While this is to date a mechanism largely experimented with in high-income countries, we think it is important because it shifts the attention of procurement policy from a market (often monopoly) price for an already developed drug to an assessment of how a drug will actually work in particular country contexts and for identified needs. Its attractiveness is in indicating ways forward in adapting procurement to a focus on population health benefit and patient needs. 

Policies are normally established for the early identification and procurement of spare parts, materials and services. Procedures are developed that specifically describe the responsibilities of the station personnel involved in the procurement function. Controls are developed and maintained throughout the procurement process to help obtain parts, materials and services in a timely manner. Deficient or non-conforming items are segregated from accessible conforming materials and deficiencies resolved in an effective and timely manner. Quality assurance records are controlled and maintained to provide documentation of acceptability for qualified spare parts and materials and to ensure traceability of parts and materials. 

Industrial policy in Brazil generally recognizes the potential of public procurement to promote competition in markets where government demand is significant, such as health. Rules have been defined for the use of public purchasing power, which allow a price preference of up to 25% for purchases from domestic producers, using a method of calculation that takes into account employment and income generation, impact on tax revenues, national development and other factors. ... 

---